相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma
Gaurav D. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
M. Bjoerkholm et al.
ANNALS OF ONCOLOGY (2007)
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma
H. -T. Arkenau et al.
ANNALS OF ONCOLOGY (2007)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)
M Adde et al.
MEDICAL ONCOLOGY (2006)
Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK
CW Cheung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide
RH Enting et al.
NEUROLOGY (2004)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:: results of the NHL-B2 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
P Feugier et al.
ANNALS OF ONCOLOGY (2004)
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
H Tilly et al.
BLOOD (2003)
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
JL Rubenstein et al.
BLOOD (2003)
CNS prophylaxis and treatment in non-Hodgkin's lymphoma: Variation in practice and lessons from the literature
R Buckstein et al.
LEUKEMIA & LYMPHOMA (2003)
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group
E Zucca et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma
SL Chua et al.
LEUKEMIA & LYMPHOMA (2002)
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model
A Hollender et al.
ANNALS OF ONCOLOGY (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis:: A GELA study on 974 patients
C Haioun et al.
ANNALS OF ONCOLOGY (2000)
分享论文
